Inmolecule Nanotech (XPAR:MLINA) Change In Receivables: €0.00 Mil (TTM As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
7 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Change In Receivables?

Inmolecule Nanotech XPAR:MLINA 7 Change In Receivables is €0.00 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 7/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's change in receivables for the quarter that ended in Dec. 2024 was €0.00 Mil. It means Inmolecule Nanotech's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Inmolecule Nanotech's change in receivables for the fiscal year that ended in Dec. 2024 was €0.00 Mil. It means Inmolecule Nanotech's Accounts Receivable stayed the same from Dec. 2023 to Dec. 2024 .

Inmolecule Nanotech's Accounts Receivable for the quarter that ended in Dec. 2024 was €1.13 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Inmolecule Nanotech's Days Sales Outstanding for the six months ended in Dec. 2024 was 103.83.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Inmolecule Nanotech's liquidation value for the six months ended in Dec. 2024 was €-2.68 Mil.

Inmolecule Nanotech  (XPAR:MLINA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Inmolecule Nanotech's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=1.127/1.981*91
=103.83

2. In Ben Graham's calculation of liquidation value, Inmolecule Nanotech's accounts receivable are only considered to be worth 75% of book value:

Inmolecule Nanotech's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.087-4.845+0.75 * 1.127+0.5 * 2.46
=-2.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Change In Receivables Related Terms

Inmolecule Nanotech Change In Receivables Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Change In Receivables Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Change In Receivables
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Change In Receivables 0.00 0.00
XPAR:MLINA
7GF Score
Inmolecule Nanotech SA XPAR:MLINA
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of €0.00 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Change In Receivables of €0.00 Mil as of Dec. 2024. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Change In Receivables too high?
Inmolecule Nanotech's current Change In Receivables is €0.00 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 7/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Change In Receivables compare to VRTX and REGN?
Inmolecule Nanotech's Change In Receivables of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Biotechnology company?
A good Change In Receivables depends on the Biotechnology industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Change In Receivables is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Change In Receivables of €0.00 Mil. The current Change In Receivables is €0.00 Mil. Inmolecule Nanotech's overall GF Score™ is 7/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Change In Receivables is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
7GF Score

Get the complete analysis for XPAR:MLINA

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price